UK NICE to expand use of life-extending drugs for the terminally ill – Update
This article was originally published in SRA
Executive Summary
The UK’s health technology assessment body has revised its policy to provide terminally ill patients suffering from rare, incurable diseases with wider access to costly life-extending medicines under the National Health Service1,2. Experts estimate that some 10,000 cancer patients a year could benefit from the move3.